The Perils of Drug Reintroduction: A Case of Generalized Bullous Fixed Drug Eruption Due to Cross Reactive NSAIDs

Ouissal ESSADEQ *

Dermatology Department, Ibn Sina University Hospital, Mohammed V University, Rabat, Morocco.

Narjess ER-RACHDY

Dermatology Department, Ibn Sina University Hospital, Mohammed V University, Rabat, Morocco.

Kaoutar Znati

Department of Anatomopathology, Ibn Sina University Hospital, Mohammed V University, Rabat, Morocco.

Mariame MEZIANE

Dermatology Department, Ibn Sina University Hospital, Mohammed V University, Rabat, Morocco.

Nadia ISMAILI

Dermatology Department, Ibn Sina University Hospital, Mohammed V University, Rabat, Morocco.

Karima SENOUCI

Dermatology Department, Ibn Sina University Hospital, Mohammed V University, Rabat, Morocco.

Laila BENZEKRI

Dermatology Department, Ibn Sina University Hospital, Mohammed V University, Rabat, Morocco.

*Author to whom correspondence should be addressed.


Abstract

Background: Generalized Bullous Fixed Drug Eruption (GBFDE) is a severe cutaneous adverse drug reaction that can mimic toxic epidermal necrolysis (TEN). Its prompt recognition is crucial to prevent severe complications and recurrence upon drug re-exposure.

Case Report: We report the case of a female patient in her fifth decade who developed widespread bullous lesions with significant epidermal detachment within 24 hours of taking Piroxicam. A previous, less severe reaction to Diclofenac was noted, suggesting cross-reactivity among NSAIDs. Given the potential severity of GBFDE and its risk of recurrence, accurate diagnosis and strict drug avoidance strategies are essential, along with hemodynamic management and the use of topical or systemic corticosteroids.

Conclusion: This case highlights the importance of thoroughly reviewing patients’ allergy history and considering a complete switch to a different pharmacological class, especially in cases of life-threatening hypersensitivity reactions.

Keywords: Fixed drug eruption, generalized bullous fixed drug eruption, adverse drug reaction, toxidermia


How to Cite

ESSADEQ, Ouissal, Narjess ER-RACHDY, Kaoutar Znati, Mariame MEZIANE, Nadia ISMAILI, Karima SENOUCI, and Laila BENZEKRI. 2025. “The Perils of Drug Reintroduction: A Case of Generalized Bullous Fixed Drug Eruption Due to Cross Reactive NSAIDs”. Asian Journal of Research in Dermatological Science 8 (1):46-52. https://doi.org/10.9734/ajrdes/2025/v8i1123.

Downloads

Download data is not yet available.